Cargando…

Positive lymph node ratio as a novel indicator of prognosis in gastric signet ring cell carcinoma: a population-based retrospective study

BACKGROUND: Lymph node status has a strong predictive effect on the prognosis of all patients with gastric cancer. It is unclear whether the positive lymph node ratio (PLNR) is a reliable prognostic factor for gastric signet ring cell carcinoma (SRCC). METHODS: Patients with SRCC were obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Feng, Lyu, Hongwei, Wang, Shuoer, Chu, Yan, Chen, Fengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797435/
https://www.ncbi.nlm.nih.gov/pubmed/35117728
http://dx.doi.org/10.21037/tcr.2020.04.04
Descripción
Sumario:BACKGROUND: Lymph node status has a strong predictive effect on the prognosis of all patients with gastric cancer. It is unclear whether the positive lymph node ratio (PLNR) is a reliable prognostic factor for gastric signet ring cell carcinoma (SRCC). METHODS: Patients with SRCC were obtained from the Surveillance, Epidemiology and End Results (SEER) database for the years 1998–2013. Cutoff values of positive lymph node ratio (PLNR) were decided using X-tile program. Survival was determined using the Kaplan-Meier method. Univariate and multivariate analyses were used to identify prognosticator of gastric signet ring cell carcinoma. RESULTS: A total of 1,884 cases were identified. 0.8 as the optimal cutoff value to separate the patients into high and low risk subsets in accordance of cancer-caused survival in SRCC patients (the number as 0.8, P<0.0001). Patients with PLNR >0.8 remained to have a poorer prognosis compared with those with PLNR <0.8 as shown by both OS (HR =2.083, 95% CI: 1.862–2.33, P<0.001) and CSS (HR =2.052, 95% CI: 1.802–2.336, P=0.014) in the multivariate cox regression model. CONCLUSIONS: PLNR is of great significance in the evaluation of prognosis for patients with SRCC.